Press Releases Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
12.42 ^USD	-1.43%		-5.48%	+18.06%

Apr. 15	Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025	Mar. 13	AQ
Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe	Mar. 12	AQ
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries	Feb. 27	AQ
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators	Feb. 22	AQ
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01	Feb. 14	AQ
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024	Nov. 21	AQ
GREENWICH LIFESCIENCES, INC. : Other Events (form 8-K)	23-04-13	AQ
GREENWICH LIFESCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-31	AQ
GREENWICH LIFESCIENCES, INC. : Other Events (form 8-K)	23-03-13	AQ
Greenwich LifeSciences Provides Year End Update	22-12-29	BU
GREENWICH LIFESCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-09	AQ
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023	22-12-01	BU
GREENWICH LIFESCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
GREENWICH LIFESCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-08-15	AQ
Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial	22-08-11	BU
Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial	22-08-03	BU
Greenwich LifeSciences Provides Financing Strategy & Corporate Update	22-07-28	BU
GREENWICH LIFESCIENCES, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22-07-12	AQ
Greenwich LifeSciences : Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed - Form 8-K	22-07-12	PU
GREENWICH LIFESCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-07-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Press Releases

Filters